Alpine BioVentures
Overview
Alpine BioVentures is a venture capital firm dedicated to investing in innovative life sciences companies. The firm focuses on identifying and supporting bold scientific ideas with the potential to transform patient care, particularly in areas such as cancer, autoimmune conditions, and orphan diseases. By licensing cutting-edge technologies and collaborating closely with scientific inventors, Alpine BioVentures aims to create impactful companies that address unmet medical needs. The firm's investment strategy encompasses a wide range of stages, from seed funding to late-stage investments, including Series A, Series B, growth, and pre-IPO rounds. Alpine BioVentures has a strong geographical focus on the United States, seeking opportunities to partner with companies that are developing groundbreaking therapies and medical solutions. The firm is particularly interested in sectors such as biotechnology, pharmaceuticals, diagnostics, and medical devices, with an emphasis on areas like immunology, oncology, neurology, cardiology, infectious diseases, regenerative medicine, genomics, proteomics, and bioinformatics. Alpine BioVentures has a proven track record of enabling disruptive scientific advancements. Notably, the firm founded and seed-funded Alpine Immune Sciences in 2015, leading to its public listing on NASDAQ under the ticker symbol 'ALPN' in 2017. Additionally, Alpine BioVentures co-invested in Mavupharma, which was acquired by AbbVie in 2019. These successes underscore the firm's commitment to partnering with visionary scientists and entrepreneurs to bring transformative medical innovations to market.
Investment Focus
- Innovative life sciences technologies
- Strong scientific leadership
- Potential for significant patient impact
- Alignment with firm's investment focus areas
Portfolio Companies
Reach Alpine BioVentures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Alpine BioVentures
What sectors does Alpine BioVentures invest in?
Alpine BioVentures invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Bioinformatics, and is based in Seattle, Washington, United States. Alpine BioVentures is listed as a venture capital in the ConnectSafely investor database.
What stage does Alpine BioVentures invest at?
Alpine BioVentures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Alpine BioVentures invest in?
Alpine BioVentures invests across United States.
Who are the partners at Alpine BioVentures?
Team members listed for Alpine BioVentures include Mitchell Gold (founder & managing partner) and Jay Venkatesan (Managing Partner).
What companies has Alpine BioVentures invested in?
Alpine BioVentures's portfolio includes Alpine Immune Sciences and Mavupharma.
How do I contact Alpine BioVentures?
Alpine BioVentures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
